Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

80.7K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
80.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.5K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.5K
DNA Bacteriophages01:26

DNA Bacteriophages

1.6K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.6K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

70.1K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
70.1K
Gene Therapy00:59

Gene Therapy

28.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.2K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

37
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
37

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical Site Infection in Lung Transplantation: Clinical Impact and Predictive Factors: Analysis From the Portuguese Lung Transplantation Center.

Transplantation proceedings·2026
Same author

A defense-like route to gene transfer agent release.

Cell chemical biology·2026
Same author

YprA-family helicases provide the missing link between diverse prokaryotic immune systems.

Cell host & microbe·2026
Same author

Persistent Mu-Opioid Receptor Dysregulation in a Pain-Facilitatory Brain Region Reinstates Hyperalgesia After Resolution of Opioid-Induced Hyperalgesia.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Antiphage defence systems Druantia III and Zorya II synergise via shared DNA intermediates in a phage-specific manner.

bioRxiv : the preprint server for biology·2026
Same author

Descending Necrotizing Mediastinitis: A 7-Year Single-Centre Experience.

Portuguese journal of cardiac thoracic and vascular surgery·2026

Related Experiment Video

Updated: Apr 17, 2026

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

7.1K

Revisiting phage therapy: new applications for old resources.

Franklin L Nobrega1, Ana Rita Costa1, Leon D Kluskens1

  • 1CEB - Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.

Trends in Microbiology
|February 25, 2015
PubMed
Summary

Phage therapy faces challenges like regulatory hurdles and phage limitations. Genetic modification offers a promising strategy to enhance bacteriophages for therapeutic use, overcoming current limitations.

Keywords:
bacteriophagesgenetic modificationphage therapyrecombineering

More Related Videos

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.6K
Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
09:23

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Published on: January 5, 2024

2.8K

Related Experiment Videos

Last Updated: Apr 17, 2026

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

7.1K
Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.6K
Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
09:23

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Published on: January 5, 2024

2.8K

Area of Science:

  • Microbiology and Biotechnology
  • Therapeutic Agent Development

Background:

  • Phage therapy, using bacteriophages to treat bacterial infections, is gaining interest as an alternative to antibiotics.
  • However, its widespread clinical application is hindered by several intrinsic limitations of bacteriophages.
  • Existing strategies to overcome these limitations have not been fully satisfactory.

Purpose of the Study:

  • To review the major challenges impeding the success of phage therapy.
  • To discuss proposed solutions for overcoming bacteriophage limitations.
  • To evaluate the advantages and disadvantages of these solutions, focusing on genetic modification.

Main Methods:

  • Literature review of existing strategies and challenges in phage therapy.
  • Analysis of proposed solutions, including genetic engineering of bacteriophages.
  • Discussion of the pros and cons of different approaches to optimize phage properties.

Main Results:

  • Several hurdles exist for phage therapy, including regulatory, safety, and public acceptance issues.
  • Various methods have been explored to address bacteriophage limitations, with varying degrees of success.
  • Genetic modification of phages presents a viable approach to engineer desirable biological properties.

Conclusions:

  • Overcoming bacteriophage limitations through strategic development is crucial for successful phage therapy.
  • Genetic engineering provides a powerful tool to tailor bacteriophages for enhanced therapeutic efficacy.
  • Further research and development in phage modification are essential for advancing phage therapy.